Status:
UNKNOWN
Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS
Lead Sponsor:
Ying Lv
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
The investigators are going to explore the diagnostic and prognostic value of circulating tumor cells and exosomes extracted from the portal venous blood obtained with endoscopic ultrasound in pancrea...
Detailed Description
As the prognosis of pancreatic cancer, a kind of malignant tumor, remains poor due to the low diagnostic rate at the early stage, there is still a significant clinical need to determine individualized...
Eligibility Criteria
Inclusion
- Aged from 18 to 80 years-old
- Suspected pancreatic masses and referred for EUS-FNA for pathology diagnosis
- Written informed consent
Exclusion
- Patients who have received adjuvant chemotherapy and other anti-tumor treatments
- Severe heart, lung, liver, kidney insufficiency, or severe bleeding disorders, severe coagulopathy or local/systemic infections, other critical illnesses
- Women who are planning to become pregnant or are pregnant or breast-feeding
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03821909
Start Date
August 1 2018
End Date
September 1 2020
Last Update
January 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Drum Tower Hospital the Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China, 210008